Entries by CTIC Team

Novocure brings Optune tech to drug trial for glioblastoma

Novocure (NSDQ:NVCR) said today that it joined a Phase Ib study to evaluate the safety of Celgene‘s (NSDQ:CELG) marizomib and temozolomide in combination with Optune for patients with newly-diagnosed glioblastoma. The trial is the first to assess Optune, the company’s “Tumor Treating Fields” delivery device, in combination with an investigational drug. Celgene and Triphase changed their ongoing Phase […]

Healthcare payment analysts Cotiviti Holdings acquires RowdMap in $70M deal

Cotiviti Holdings, a health IT vendor that specializes in analyzing healthcare payments for accuracy, has slapped down $70 million for healthcare analytics business RowdMap based in Louisville. The acquisition is intended to diversify the company’s analytics tools. Doug Williams, Cotiviti CEO, noted in a news release that the need for its services has increased in line with the shift toward […]

Forget antimicrobials, Evelo just raised $50M for its pro-microbial approach

Evelo Biosciences is doing pretty well for a preclinical company in an exploratory field. The 2014 startup has already executed a merger and raised $100 million in venture financing. The latest installment, announced Tuesday, came as a $50 million Series B courtesy of its founding and principal investor, Flagship Pioneering. GV (formerly Google Ventures), Celgene, Mayo Clinic, and Alexandria Venture […]

New York Approves Guardant Health’s Liquid Biopsy Test

May 24, 2017 | staff reporter NEW YORK (GenomeWeb) – Guardant Health today announced the Guardant360 assay has been approved by New York State’s Clinical Laboratory Evaluation Program. The assay is the first liquid biopsy permitted by the program, which Guardant said is one of the most demanding lab certification programs in the country, and the […]

Deep Genomics Shifts Focus to Genetic Medicines

By Allison Proffitt  May 12, 2017 | In August 2015 when Deep Genomics first launched, co-founder Brendan Frey made a prediction. “There’s a sea change coming,” he told Bio-IT World. “People are going to be focusing now on the machine learning component and trying to understand what the genome means, not just sequence a bunch […]

For some, access to healthcare could start with at-home lab testing

Most at-home lab testing devices like Scanadu and Cor are still waiting for FDA approval, but simple lab testing can still be done in the confines of your own home and then shipped to a lab and that’s led to a handful of new startups offering services like STD or food allergy tests. Everlywell, an […]

Tencent increases its focus on artificial intelligence

When it comes to artificial intelligence (AI) and Chinese tech companies, thoughts often begin and end with Baidu. But Tencent, Asia’s second highest-valued tech company behind Alibaba, has reminded the world that it too is investing in the field. Search giant Baidu was one of the first to make a major commitment to deep learning. […]

Uber’s autonomous test cars return to the road in San Francisco today

Uber has confirmed that its small fleet of autonomous vehicles in San Francisco will be back on the road today. The company grounded its entire self-driving test fleet in the U.S. on Saturday, following an accident involving one of its vehicles in Arizona earlier in the day. “We are resuming our development operations in San […]

Editas, Allergan Ink $90M CRISPR-Based Eye Drug Deal

NEW YORK (GenomeWeb) – Editas Medicine has signed a deal potentially worth more than $90 million, giving Allergan the exclusive rights to license certain of its CRISPR genome editing-based treatments for eye diseases. Under the terms of the deal, Allergan subsidiary Allergan Pharmaceuticals International Limited will have exclusive options to license up to five of […]